Cost Of Revenues

9 Months Ended

Sep. 30, 2014

Cost of Revenue [Abstract]

Cost of Revenues

NOTE 15. COST OF REVENUES

The components of Cost of revenues for the three and nine months ended September 30, 2014 and 2013 were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Cost of net pharmaceutical product sales	$	341,193	$	221,823	$	857,288	$	673,643
Cost of device revenues	38,006		36,013		119,611		111,987
Total cost of revenues	$	379,199	$	257,836	$	976,899	$	785,630